-
1.发明授权PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR NOTFALLEMPFÄNGNISVERHÜTUNG 有权药剂师ZUSAMMENSETZUNG ZURNOTFALLEMPFÄNGNISVERHÜTUNG
公开(公告)号：EP2445491B1
公开(公告)日：2017-03-08
申请号：EP10722968.4
申请日：2010-06-10
IPC分类号： A61K31/567 , A61K31/5415 , A61K45/06 , A61P5/34
CPC分类号： A61K31/57 , A61K31/18 , A61K31/192 , A61K31/196 , A61K31/405 , A61K31/415 , A61K31/5415 , A61K31/542 , A61K31/567 , A61K31/575 , A61K31/585 , A61K45/06 , A61K2300/00
-
2.发明公开
公开(公告)号：EP2785707A1
公开(公告)日：2014-10-08
申请号：EP12794931.1
申请日：2012-11-26
发明人： BRÄUER, Nico , MENGEL, Anne , RÖHN, Ulrike , ROTGERI, Andrea , BUCHMANN, Bernd , LINDENTHAL, Bernhard , TER LAAK, Antonius
IPC分类号： C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D407/14 , C07D413/14 , C07D417/14 , A61K31/416 , A61K31/4439 , A61K31/4545 , A61K31/506 , A61K31/5377 , A61P15/00
CPC分类号： C07D417/14 , A61K31/416 , A61K31/454 , A61K31/4545 , A61K31/506 , A61K31/513 , A61K31/5377 , A61K45/06 , C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07D407/14 , C07D413/14
摘要： The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.
摘要翻译： 本发明涉及通式（I）的新型2H-吲唑，其制备方法及其用于制备用于治疗与EP2受体相关的疾病和适应症的药物的用途。
-
公开(公告)号：EP2785707B1
公开(公告)日：2018-01-24
申请号：EP12794931.1
申请日：2012-11-26
发明人： BRÄUER, Nico , MENGEL, Anne , RÖHN, Ulrike , ROTGERI, Andrea , BUCHMANN, Bernd , LINDENTHAL, Bernhard , TER LAAK, Antonius
IPC分类号： C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D407/14 , C07D413/14 , C07D417/14 , A61K31/416 , A61K31/4439 , A61K31/4545 , A61K31/506 , A61K31/5377 , A61P15/00
CPC分类号： C07D417/14 , A61K31/416 , A61K31/454 , A61K31/4545 , A61K31/506 , A61K31/513 , A61K31/5377 , A61K45/06 , C07D401/06 , C07D401/14 , C07D403/06 , C07D403/14 , C07D405/14 , C07D407/14 , C07D413/14
摘要： The present invention relates to novel 2H-indazoles of the general formula (I), methods for the preparation thereof and the use thereof for the production of pharmaceutical agents for the treatment of diseases and indications which are linked with the EP2-receptor.
-
-
搜索结果
3 条记录 (耗时 0.016 秒)
